home / stock / ambs / ambs news

AMBS News and Press, Amarantus BioScience Holdings Inc From 10/24/19

Stock Information
Company Name: Amarantus BioScience Holdings Inc
Stock Symbol: AMBS
Market: OTC
Website: amarantus.com
Menu
AMBS AMBS Quote AMBS Short AMBS News AMBS Articles AMBS Message Board
Get AMBS Alerts

News, Short Squeeze, Breakout and More Instantly...
AMBS - Todos Medical to Present at Dawson James Small Cap Growth Conference

REHOVOT, Israel, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced that Company management will prese...
AMBS - Todos Medical and Orot+ Announce First Patient Enrolled in Pre-Commercial Launch Preparations of TM-B1 and TM-B2 Breast Cancer Blood Screening Tests in Europe

REHOVOT, Israel, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) , a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, and Orot + , the operational division of Orot-L...

AMBS - Todos Medical Signs Binding Term Sheet with HWH World for Network Marketing of Blood Tests for the Early Detection of Breast Cancer

REHOVOT, Israel and SINGAPORE, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) , a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced it has entered in...

AMBS - Todos Medical Enters into MOU to Expand Existing Early Detection Breast Cancer Blood Test Distribution Partnership with Orot+ into Japan

REHOVOT, Israel, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) , a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced that the Company  has ente...
AMBS - Todos Medical Appoints Dr. Jorge Leon as Medical Advisor

REHOVOT, Israel, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, such as Alzheimer's disease, today announced the a...

AMBS - Todos Medical Announces Positive Alzheimer's Biomarker Clinical Data from LymPro vs. Amyloid PET Interim Analysis

REHOVOT, Israel, July 15, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) , a clinical-stage in-vitro diagnostic company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, such as Alzheimer's disease (AD), today anno...

AMBS - Todos Medical to Appoint Dr. Paula Trzepacz As Chief Medical Officer And Files New Patent Application

Joint venture Breakthrough Diagnostics files new patent application covering Alzheimer’s blood diagnostic LymPro Test clinical correlation with amyloid PET imaging Preliminary Data on LymPro vs. amyloid PET to be released during AAIC 2019 REHOVOT, Israel, July 12, 2019 (GLOBE N...
AMBS - Todos Medical Announces Launch of Public Offering

REHOVOT, Israel, July 11, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, such as Alzheimer's disease, today announced ...

AMBS - Todos Medical to Sponsor the Investacure 'Cure Coin Awards Reception' for Alzheimer's and CTE Research at AAIC 2019 in Los Angeles

REHOVOT, Israel, June 27, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced that it will be sponsoring the Inv...

AMBS - Amarantus Enters into Letter of Intent with The Alchemists Kitchen to Establish Joint Venture for Research and Commercialization of Hemp and Herbal Smokables for Addiction Treatment Including Smoking Cessation

NEW YORK, NY, June 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Amarantus Bioscience Holdings, Inc . (OTC Pink: AMBS) (the “Company,” or AMBS), a US-based JLABS-alumnus biotechnology holding company developing proprietary orphan neurologic, regenerative medicine and...
Previous 10 Next 10